The property manager and workspace operator has teamed up with venture firm Nippon Venture Capital for a corporate VC fund.

UCL Technology Fund-backed gene therapy developer Orchard Therapeutics raised $200m in an offering that could possibly close at $230m.

FinUp has returned to lead a $70m series C round for Akulaku, whose other existing shareholders reportedly include Legend Capital.

Athenahealth-backed PatientPop has now raised a total of $75m in funding, after receiving an undisclosed in a round led by Leerink Transformation Partners.

Real estate developer Century Golden Resources Group is among the contributors to the latest fund for venture firm Fortune Venture Capital, which has closed at $667m.

Leiden University has backed a series A round co-led by Evonik and VisVires New Protein.

UNC-Chapel Hill has become the latest university to join forces with Deerfield Management and launch a $65m commercialisation fund.

Stanford-StartX Fund has exited business intelligence software provider DataFox in an acquisition of undisclosed size by Oracle.

Carmaker Hyundai has teamed up with Yield Capital to set up a hydrogen-related investment fund and has targeted a $100m close.

Rogue Venture Partners, whose largest limited partner is Oregon State University, has led a $3.7m funding round for Lensabl.